BOLT – bolt biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Bolt Biotherapeutics (NASDAQ:BOLT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Bolt Biotherapeutics (NASDAQ:BOLT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Bolt Biotherapeutics (NASDAQ:BOLT) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Form SCHEDULE 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Form SCHEDULE 13G/A Bolt Biotherapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Form 10-Q Bolt Biotherapeutics, For: Sep 30
Form 8-K Bolt Biotherapeutics, For: Nov 12
Form 4 Bolt Biotherapeutics, For: Oct 24 Filed by: Quinn William P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.